Publicaciones (32) Publicaciones en las que ha participado algún/a investigador/a

2007

  1. 18F-FDG metabolism in a rat model of chronic infarction: A 17-sector semiquantitative analysis

    NuklearMedizin, Vol. 46, Núm. 4, pp. 149-154

  2. A worldwide perspective of atypical pathogens in community-acquired pneumonia

    American Journal of Respiratory and Critical Care Medicine, Vol. 175, Núm. 10, pp. 1086-1093

  3. Asistencia biventricular con cardiectomía

    Revista Espanola de Cardiologia, Vol. 60, Núm. 9, pp. 983

  4. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure

    Journal of Hypertension, Vol. 25, Núm. 10, pp. 2148-2157

  5. Association of increased plasma cardiotrophin-1 with inappropriate left ventricular mass in essential hypertension

    Hypertension, Vol. 50, Núm. 5, pp. 977-983

  6. Aterosclerosis en las enfermedades inflamatorias

    Medicina Clinica, Vol. 128, Núm. 19, pp. 749-756

  7. Cardiac resynchronization therapy: Predictive factors of unsuccessful left ventricular lead implant

    European Heart Journal, Vol. 28, Núm. 4, pp. 450-456

  8. Cumplimiento con las guias nacionales en pacientes hospitalizados con neumonia adquirida en la comunidad. Resultados del estudio CAPO en Argentina

    Medicina, Vol. 67, Núm. 6 II, pp. 709-713

  9. Endovascular treatment of thoracoabdominal aneurysms with prior visceral revascularisation

    Angiologia, Vol. 59, Núm. 2, pp. 191-197

  10. Following up patients with pacemakers. Pacemaker system dysfunction. Effect of incorrect indications or programming: pacemaker syndrome

    Revista Espanola de Cardiologia Suplementos, Vol. 7, Núm. G

  11. Ictus isquémico secundario a mixoma auricular izquierdo

    Anales de Medicina Interna, Vol. 24, Núm. 2, pp. 84-86

  12. Identification of a Potential Cardiac Antifibrotic Mechanism of Torasemide in Patients With Chronic Heart Failure

    Journal of the American College of Cardiology, Vol. 50, Núm. 9, pp. 859-867

  13. Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 4, pp. 916-922

  14. Impact on Renal Function of the Use of Sirolimus in Cardiac Transplantation

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2401-2402

  15. Independent association of matrix metalloproteinase-10, cardiovascular risk factors and subclinical atherosclerosis

    Journal of Thrombosis and Haemostasis, Vol. 5, Núm. 1, pp. 91-97

  16. Influence of Induction Therapy, Immunosuppressive Regimen and Anti-viral Prophylaxis on Development of Lymphomas After Heart Transplantation: Data From the Spanish Post-Heart Transplant Tumour Registry

    Journal of Heart and Lung Transplantation, Vol. 26, Núm. 11, pp. 1105-1109

  17. Metaloproteasa-10 (estromelisina-2): Un nuevo marcador de aterosclerosis subclínica

    Clinica e Investigacion en Arteriosclerosis, Vol. 19, Núm. 3, pp. 122-128

  18. Metaloproteasa-10 (estromelisina-2): un nuevo marcador de aterosclerosis subclínica

    Clínica e investigación en arteriosclerosis, Vol. 19, Núm. 3, pp. 122-128

  19. Metaloproteasas, remodelado vascular y síndromes aterotrombóticos

    Revista Espanola de Cardiologia, Vol. 60, Núm. 9, pp. 959-967

  20. Myocardial fibrosis and diastolic dysfunction in patients with hypertension: Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

    Journal of Hypertension, Vol. 25, Núm. 9, pp. 1958-1966